Target Name: MTUS1
NCBI ID: G57509
Review Report on MTUS1 Target / Biomarker Content of Review Report on MTUS1 Target / Biomarker
MTUS1
Other Name(s): microtubule associated tumor suppressor 1 | ATBP | FLJ14295 | DKFZp686F20243 | MP44 | KIAA1288 | Transcription factor MTSG1 | DKFZp586D1519 | AT2 receptor-binding protein | AT2 receptor-interacting protein | ATIP | mitochondrial tumor suppressor gene 1 | MTUS1 variant 1 | Mitochondrial tumor suppressor gene 1 | Mitochondrial tumor suppressor 1 | MTUS1_HUMAN | angiotensin-II type 2 receptor-interacting protein | ICIS | Microtubule-associated tumor suppressor 1 | microtubule associated scaffold protein 1 | AT2R binding protein | erythroid differentiation-related | ATIP3 | Erythroid differentiation-related | Microtubule associated scaffold protein 1, transcript variant 1 | Angiotensin-II type 2 receptor-interacting protein | MTSG1 | Microtubule-associated tumor suppressor 1 (isoform 1) | transcription factor MTSG1

MTUS1: Non-coding RNA Molecule Linked To Cancer Development

Microtubule Associated Tumor Suppressor 1 (MTUS1) is a non-coding RNA molecule that is expressed in a variety of tissues and cell types. MTUS1 has been shown to play a role in the regulation of cell division and has been linked to the development and progression of a number of tumors, including neurofibromatosis and melanoma.

In addition to its role in cell division, MTUS1 has also been shown to function as a protein suppressor of tumor suppressor genes. This is accomplished through the interaction of MTUS1 with the tumor suppressor protein, p53. When MTUS1 binds to p53, it can inhibit the functions of p53 and other tumor suppressor proteins, leading to the activation of gene transcription and the growth and proliferation of cancer cells.

MTUS1 has also been shown to play a role in the regulation of the cell cycle. It is a component of the microtubule, which is the protein structure that organizes the cytoskeleton and controls the movement of cells in the cell cycle. MTUS1 has also been shown to play a role in the regulation of the length and dynamics of microtubules, which can affect the speed and efficiency of cell division.

In addition to its role in cell division and the cell cycle, MTUS1 has also been shown to play a role in the regulation of cell adhesion. MTUS1 has been shown to interact with a variety of adhesion molecules, including cadherins and integrins, and has been shown to contribute to the regulation of cell adhesion and the formation of tight junctions.

MTUS1 has also been shown to play a role in the regulation of cellular processes that are important for the development and progression of cancer. For example, MTUS1 has been shown to play a role in the regulation of the angiogenesis that occurs during the development of cancer. . In addition, MTUS1 has also been shown to play a role in the regulation of cell survival and the progression of cancer.

MTUS1 has also been shown to play a role in the inflammation of inflammation. MTUS1 has been shown to interact with regulation with a variety of immune cells and has been shown to contribute to the regulation of the immune response.

In conclusion, MTUS1 is a non-coding RNA molecule that has been shown to play a role in the regulation of cell division, the cell cycle, cell adhesion, and the development and progression of cancer. As a result, MTUS1 may be a potential drug target or biomarker for the treatment of a variety of diseases. Further research is needed to fully understand the role of MTUS1 in the regulation of cellular processes and to develop effective treatments for the treatment of cancer and other diseases.

Protein Name: Microtubule Associated Scaffold Protein 1

Functions: Cooperates with AGTR2 to inhibit ERK2 activation and cell proliferation. May be required for AGTR2 cell surface expression. Together with PTPN6, induces UBE2V2 expression upon angiotensin-II stimulation. Isoform 1 inhibits breast cancer cell proliferation, delays the progression of mitosis by prolonging metaphase and reduces tumor growth

The "MTUS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MTUS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MTUS1-DT | MTUS2 | MTUS2-AS1 | MTVR2 | MTX1 | MTX2 | MTX3 | mu-Calpain (calpain 1) | MUC1 | MUC12 | MUC13 | MUC15 | MUC16 | MUC17 | MUC19 | MUC2 | MUC20 | MUC20P1 | MUC21 | MUC22 | MUC3A | MUC3B | MUC4 | MUC5AC | MUC5B | MUC6 | MUC7 | MUC8 | Mucin | MUCL1 | MUCL3 | MUL1 | Multisubunit histone acetyltransferase complex | MUPP | MUS81 | Muscarinic Acetylcholine Receptor (mAChR) | MUSK | MUSTN1 | MUTYH | MVB12A | MVB12B | MVD | MVK | MVP | MX1 | MX2 | MXD1 | MXD3 | MXD4 | MXI1 | MXRA5 | MXRA5Y | MXRA7 | MXRA8 | MYADM | MYADML | MYADML2 | MYB | MYBBP1A | MYBL1 | MYBL2 | MYBPC1 | MYBPC2 | MYBPC3 | MYBPH | MYBPHL | MYC | MYCBP | MYCBP2 | MYCBP2-AS1 | MYCBPAP | MYCL | MYCL-AS1 | MYCLP1 | MYCN | MYCNOS | MYCNUT | MYCT1 | MYD88 | MYDGF | MYEF2 | Myelin Protein | MYEOV | MYF5 | MYF6 | MYG1 | MYH1 | MYH10 | MYH11 | MYH13 | MYH14 | MYH15 | MYH16 | MYH2 | MYH3 | MYH4 | MYH6 | MYH7 | MYH7B | MYH8